Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N05CD08	MIDAZOLAM HAMELN	G	Midazolam (HCl) - 5mg/ml	5mg/ml	Injectable solution	561,726 L.L
N05CD08	MIDAZOLAM PANPHARMA	G	Midazolam - 5mg/ml	5mg/ml	Injectable solution	826,463 L.L
J01MA12	LEVOFLOXACIN- HAMELN	G	Levofloxacin - 500mg/100ml	5mg/ml	Injectable solution	1,632,769 L.L
J01MA12	LEVOFLOXACIN NORMON	G	Levofloxacin - 500mg/100ml	5mg/ml	Injectable solution	27,147,388 L.L
J01MA12	LEVOFLOXACINA BASI	G	Levofloxacin - 5mg/ml	5mg/ml	Injectable solution	56,572,950 L.L
R03AC02	VENTOLIN	B	Salbutamol (sulfate) - 5mg/ml	5mg/ml	Solution	403,153 L.L
S01AE07	MOXITEC	G	Moxifloxacin (HCl) - 5mg/ml	5mg/ml	Drops solution	464,970 L.L
S01AE07	VIGAMOX	G	Moxifloxacin (HCl) - 5mg/ml	5mg/ml	Drops solution	670,577 L.L
C08CA05	NIFE-PAR	G	Nifedipine - 5mg/ml	5mg/ml	Solution	38,120,008 L.L
L01CD01	ABRAXANE	BioTech	Paclitaxel Albumin- bound - 5mg/ml	5mg/ml	Injectable powder for dispersion	17,850,751 L.L
L01XA03	OXALIPLATIN HOSPIRA	G	Oxaliplatin - 100mg/20ml	5mg/ml	Injectable concentrated solution	8,471,583 L.L
L01XA03	OXALIPLATIN HOSPIRA	G	Oxaliplatin - 50mg/10ml	5mg/ml	Injectable concentrated solution	3,450,988 L.L
A10BX16	MOUNJARO KWIKPEN	B	Tirzepatide - 5mg/dose	5mg/dose	Injectable solution	39,601,065 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 5mg, Metformin HCl - 850mg	5mg/850mg	Tablet, film coated	3,287,711 L.L
N05CD08	MIDAZOLAM HAMELN	G	Midazolam (HCl) - 5mg/5ml	5mg/5ml	Injectable solution	529,474 L.L
N05CD08	MIDAZOLAM NORMON.	G	Midazolam - 5mg/5ml	5mg/5ml	Injectable solution	618,168 L.L
N05CD08	MIDAZOLAM PANPHARMA	G	Midazolam - 5mg/5ml	5mg/5ml	Injectable solution	697,454 L.L
R06AD02	PROMETHAZINE HYDROCHLORIDE	G	Promethazine HCl - 5mg/5ml	5mg/5ml	Syrup	204,776 L.L
R06AE07	CETIMED	G	Cetirizine (dihydrochloride) - 5mg/5ml	5mg/5ml	Solution	415,951 L.L
R06AE07	FINALLERG	G	Cetirizine (dihydrochloride) - 5mg/5ml	5mg/5ml	Solution	170,668 L.L
R06AX13	CLARITINE	B	Loratadine (micronised) - 5mg/5ml	5mg/5ml	Syrup	430,030 L.L
R06AX13	CLARA	G	Loratadine (micronised) - 5mg/5ml	5mg/5ml	Syrup	215,015 L.L
R06AX13	LORINE	G	Loratadine (micronised) - 5mg/5ml	5mg/5ml	Syrup	215,015 L.L
A03BB01	SCOPINAL	G	Butylscopolamine bromide - 5mg/5ml	5mg/5ml	Syrup	210,983 L.L
A03FA03	MOTILIUM ORAL	B	Domperidone - 5mg/5ml	5mg/5ml	Suspension	377,620 L.L
A03FA03	DOMIDONE CHAPHA SUGAR FREE	G	Domperidone - 5mg/5ml	5mg/5ml	Suspension	319,963 L.L
A03FA03	FARCOTILIUM	G	Domperidone - 5mg/5ml	5mg/5ml	Suspension	115,570 L.L
N07AA01	NEOSTIGMINE RENAUDIN	G	Neostigmine - 5mg/5ml	5mg/5ml	Injectable solution	2,460,576 L.L
C01DA02	NITRODERM TTS 5	B	Glyceryl trinitrate - 5mg/24h	5mg/24h	Patch	683,159 L.L
H02AB02	DEXAMETHASON-PANPHARMA	G	Dexamethasone - 5mg/1ml	5mg/1ml	Injectable solution	368,213 L.L

...

189